Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Social Capital Suvretta Holdings Corp. II DNAB NASDAQ

NASDAQ Capital Marke • Financial Services • Shell Companies • US • USD

SharesGrow Score
48/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Social Capital Suvretta Holdings Corp. II (DNAB) is a Shell Companies company in the Financial Services sector, currently trading at $10.36. It has a SharesGrow Score of 44/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Net income is $6M, growing at +0%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $0 against $246M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 2.5 (strong liquidity). Debt-to-assets is 0%. Total assets: $254M.

SharesGrow 7-Criteria breakdown: Value 15/100 (Fail), Growth ?/100 (Fail), Past 50/100 (Partial), Health 100/100 (Pass), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

DNAB SharesGrow Score Overview

48/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 15/100
Valuation — P/E, PEG, Forward PEG
GROWTH 0/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — DNAB

✗
VALUE Fail
15/100
DNAB trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
—
GROWTH N/A
N/A
No analyst coverage available for this stock.
~
PAST Partial
50/100
DNAB: 1 / 2 years profitable. weak. Score = 1 / 2 × 100. ≥ 80 = Pass.
View details →
✓
HEALTH Pass
100/100
Balance sheet DNAB: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 2.5 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
DNAB: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range9.73-11.02
Volume142.51K
Avg Volume (30D)77.48K
Market Cap$330.22M
Beta (1Y)0.00
Share Statistics
EPS (TTM)0.25
Shares Outstanding$25.64M
IPO Date2021-06-30
CEOChamath Palihapitiya
Financial Highlights & Ratios
EBITDA$-862.75K
Net Income$6.35M
Operating Income$-862.75K
Total Cash$128.65K
Net Debt$-128.65K
Total Assets$254M
Price / Earnings (P/E)41.4
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD

Price Chart

Track all markets on TradingView
DNAB
Social Capital Suvretta Holdings Corp. II ↗  ·  NASDAQ Capital Marke
Financial Services • Shell Companies
9.73 52WK RANGE 11.02

People Also View

SCUA
SCUA
Sculptor Acquisition Corp I
$10.52
+0.10%
 BNNR
BNNR
Banner Acquisition Corp.
$10.30
+0.10%
 LVAC
LVAC
LAVA Medtech Acquisition Corp.
$10.43
+0.00%
 PHYT
PHYT
Pyrophyte Acquisition Corp.
$11.60
+0.41%
 IVCPU
IVCPU
Swiftmerge Acquisition Corp.
$9.20
-1.29%
 NUBI
NUBI
Nubia Brand International Corp.
$4.53
-21.35%
 CLAYU
CLAYU
Chavant Capital Acquisition Corp.
$10.97
+18.34%
 SKYAU
SKYAU
Skydeck Acquisition Corp.
$10.10
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message